Work

Phase II trial of bevacizumab and sorafenib in recurrent ovarian cancer patients with or without prior-bevacizumab treatment

Year: 2020

Type: article

Study design: Clinical Trial

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2020.07.031

Authors: Jung-Min Lee, Christina M. Annunziata, John L. Hays, Liang Cao, Peter Choyke, Minshu Yu, Daniel An, Ismail Baris Turkbey, Lori M. Minasian, Seth M. Steinberg, Helen Chen, John Wright, Elise C. Kohn

Institutions: National Cancer Institute, Center for Cancer Research, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Awards: G6374948078, G9000185598

OpenAlex ID: W3046600912

FWCI: 3.068

Cites: 42

Cited by: 30

Related to: 10